Red cell-derived microparticles (RMP) as haemostatic agent.
about
Procoagulant profile in patients with immune thrombocytopenia.Red blood cells ageing markers: a multi-parametric analysisHemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injury.Biological properties of extracellular vesicles and their physiological functions.Microparticles variability in fresh frozen plasma: preparation protocol and storage time effects.Molecular mechanisms of erythrocyte aging.Platelet and red blood cell interactions and their role in rheumatoid arthritis.Fibrinogen, red blood cells, and factor XIII in venous thrombosis.Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.Role of red blood cells in haemostasis and thrombosis.Microparticles in sickle cell anaemia: promise and pitfalls.Small-Scale Perfusion Bioreactor of Red Blood Cells for Dynamic Studies of Cellular Pathways: Proof-of-Concept.Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016.Microparticles from stored red blood cells enhance procoagulant and proinflammatory activity.Microparticles Formed During Storage of Red Blood Cell Units Support Thrombin Generation.Redox Status, Procoagulant Activity, and Metabolome of Fresh Frozen Plasma in Glucose 6-Phosphate Dehydrogenase Deficiency.Growing thrombi release increased levels of CD235a(+) microparticles and decreased levels of activated platelet-derived microparticles. Validation in ST-elevation myocardial infarction patients.Proteomics of Stored Red Blood Cell Membrane and Storage-Induced Microvesicles Reveals the Association of Flotillin-2 With Band 3 Complexes.Pharmacokinetics of Human Red Blood Cell Microparticles Prepared Using High-Pressure Extrusion Method.New players in haemostasis and thrombosis.
P2860
Q33436189-C90D85F8-5C98-4762-8455-7080A4B34578Q33739523-3CCC3BDB-F280-4D79-9A46-3E4257121BDDQ35216740-0B09907C-8220-4807-8C80-410FD40DA0E2Q35611763-2C079784-D23D-4E02-9D8B-22E16FF038BDQ37032283-2D5B3FE0-D903-46C8-8018-C2C08CB4853BQ38388853-9ACF858E-658C-4C38-AE94-7B03CD7B97D4Q38523001-4D9B7273-4EBD-44BA-8C8B-21875DCAEE60Q38543294-BD43F36C-F3D4-4983-B31C-0F4C67991F0AQ38760096-7E438491-E257-4F3E-A17A-3EBF2AB6CCF7Q38811610-95A4852E-CD52-4B08-B9FF-B0DB63951B94Q38823104-E40E3884-83DE-4C12-8B2D-E4341FBE4B1AQ39641422-CDB448C9-EA87-474C-84DB-4E214EE572C1Q46525276-46F18438-EDD7-4FB6-985B-4276FF279616Q48000955-0110D92A-B58C-4B06-BF85-66611E9C2CA1Q49684267-0E80C846-5866-460A-B540-5E3DA03B86BAQ49828884-738A847D-EEB5-466F-A571-99B0161E044BQ53396661-D872324D-DFD4-49F3-8109-CB9913E183FDQ55092038-6D510530-F50D-4328-9C92-71177835C471Q55379791-41097C77-643E-485D-A1E0-F7592F5056FCQ55652396-DAEB80E9-81C0-4540-AA70-78B58CB3A71E
P2860
Red cell-derived microparticles (RMP) as haemostatic agent.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Red cell-derived microparticles (RMP) as haemostatic agent.
@ast
Red cell-derived microparticles (RMP) as haemostatic agent.
@en
type
label
Red cell-derived microparticles (RMP) as haemostatic agent.
@ast
Red cell-derived microparticles (RMP) as haemostatic agent.
@en
prefLabel
Red cell-derived microparticles (RMP) as haemostatic agent.
@ast
Red cell-derived microparticles (RMP) as haemostatic agent.
@en
P2093
P356
P1476
Red cell-derived microparticles (RMP) as haemostatic agent.
@en
P2093
Carlos Bidot
Lawrence L Horstman
Max E Johansen
Yeon S Ahn
P304
P356
10.1160/TH12-12-0941
P577
2013-09-12T00:00:00Z